deltatrials

Psoriasis Trials in New York, United States

Conditions / Psoriasis / New York, United States

Clinical trials for Psoriasis investigate a range of treatment strategies and patient populations.

96 total trials for this combination

Showing top 10 of 96 trials

Trials

NCT ID Title Status Phase
NCT03047395 A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) COMPLETED PHASE3
NCT04036435 Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis ACTIVE_NOT_RECRUITING PHASE3
NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO RECRUITING
NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO RECRUITING
NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO RECRUITING
NCT06588283 Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight ACTIVE_NOT_RECRUITING PHASE3
NCT00508547 Psoriasis Longitudinal Assessment and Registry ACTIVE_NOT_RECRUITING
NCT01856647 Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects TERMINATED
NCT01163253 A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis TERMINATED PHASE3
NCT00261976 A Long-term Safety Study of Infliximab (Remicade) COMPLETED

Related Pages